We have shown that the transient changes in the expression of luteinizing hormone/ choriogonadotropin receptor (LHCGR) messenger RNA (mRNA) during the ovarian cycle occurs, at least in part, through a posttranscriptional mechanism involving an LHCGR mRNA-binding protein (LRBP). Eukaryotic initiation factor 5A (eIF5A), an LRBP-interacting protein, participates in this process. eIF5A undergoes hypusination, a unique posttranslational modification that is necessary for its functions. This study examined the role of eIF5A in follicle-stimulating hormone (FSH)-induced LHCGR expression during follicular growth. Treatment of primary cultures of rat granulosa cells with FSH and 17b-estradiol (E2) showed a time-dependent increase in LHCGR mRNA expression. Conversely, inhibition of endogenous hypusination of eIF5A using N1-guanyl-1,7-diaminoheptane (GC7), a hypusination inhibitor, showed a greater increase in LHCGR mRNA expression over that produced by FSH and E2 alone. Further studies were carried out to determine the mechanism by which inhibition of hypusination of eIF5A causes an increase in LHCGR mRNA expression. Because LHCGR expression is negatively regulated by LRBP, the effect of inhibiting hypusination of eIF5A on LRBP expression was examined. The results showed a decrease in the expression of LRBP mRNA and protein when hypusination of eIF5A was inhibited by GC7. Because LRBP promotes LHCGR mRNA degradation, the results of this study support the notion that by inhibiting eIF5A hypusination, FSH reduces the expression of LRBP. This increases LHCGR mRNA expression by abrogating the inhibitory action of LRBP. (Endocrinology 158: 2672(Endocrinology 158: -2679(Endocrinology 158: , 2017 S timulation of follicular growth by follicle-stimulating hormone (FSH) is associated with increased expression of luteinizing hormone/choriogonadotropin receptors (LHCGRs) in granulosa cells (1, 2). FSH has been known to induce LHCGR expression in the granulosa cells through activation of adenylyl cyclase and increased cyclic adenosine monophosphate production (3, 4). Appropriate levels of expression of LHCGR are critical for luteinizing hormone (LH) to exert its effect on ovarian function, including preovulatory steroidogenesis, ovulation, corpus luteum formation, and luteal cell steroidogenesis (5-7). During the ovarian cycle, LHCGR expression undergoes substantial changes, as evidenced by an increase in LHCGR messenger RNA (mRNA) expression by the growing follicles in response to the combined actions of FSH and estradiol, followed by a transient downregulation in response to the preovulatory LH surge (8). Previous studies from our laboratory have effectively documented that the transient ligand-induced downregulation of LHCGR mRNA, at least in part, occurs through a posttranscriptional mechanism involving accelerated degradation of LHCGR mRNA that is mediated by LHCGR mRNA-binding protein (LRBP) (9-12). Further studies on the mechanism underlying the
S timulation of follicular growth by follicle-stimulating hormone (FSH) is associated with increased expression of luteinizing hormone/choriogonadotropin receptors (LHCGRs) in granulosa cells (1, 2) . FSH has been known to induce LHCGR expression in the granulosa cells through activation of adenylyl cyclase and increased cyclic adenosine monophosphate production (3, 4) . Appropriate levels of expression of LHCGR are critical for luteinizing hormone (LH) to exert its effect on ovarian function, including preovulatory steroidogenesis, ovulation, corpus luteum formation, and luteal cell steroidogenesis (5) (6) (7) . During the ovarian cycle, LHCGR expression undergoes substantial changes, as evidenced by an increase in LHCGR messenger RNA (mRNA) expression by the growing follicles in response to the combined actions of FSH and estradiol, followed by a transient downregulation in response to the preovulatory LH surge (8) . Previous studies from our laboratory have effectively documented that the transient ligand-induced downregulation of LHCGR mRNA, at least in part, occurs through a posttranscriptional mechanism involving accelerated degradation of LHCGR mRNA that is mediated by LHCGR mRNA-binding protein (LRBP) (9) (10) (11) (12) . Further studies on the mechanism underlying the LRBP-mediated regulation of LHCGR mRNA revealed that LRBP serves as a docking site for LHCGR mRNA and recruits additional proteins, as revealed by yeast two-hybrid screening (12) (13) (14) . Eukaryotic initiation factor 5A (eIF5A) was identified as one of the proteins that interact with LRBP and lead to the degradation of LHCGR mRNA by facilitating the transport of LHCGR mRNA-LRBP complex to P bodies for degradation (15) (16) (17) .
EIF5A is a highly conserved 17-kDa protein that is expressed ubiquitously in all cells. It undergoes hypusination, a unique posttranslational modification achieved by the addition of hypusine residue to the «-amino group of lysine; this modification of eIF5A is essential for many of its functions (18, 19) . eIF5A participates in diverse cellular processes, including protein translation (20) (21) (22) , nucleocytoplasmic transport of RNA (23) , cell proliferation (18) , inflammation, and apoptosis (24, 25) . Our recent studies have shown that eIF5A undergoes hypusination in the ovary, a process necessary for the loss of LHCGR expression during ligand-induced downregulation. Furthermore, we showed that inhibition of eIF5A hypusination resulted in restoration of functional LHCGR expression (16, 17) . In the current study, we extended these findings to examine the role of eIF5A hypusination on FSH-induced LHCGR mRNA expression, using primary cultures of rat granulosa cells. Our results show that inhibition of eIF5A hypusination plays a regulatory role in the FSH-induced LHCGR mRNA expression effect that is mediated by changes in the levels of LH receptor mRNA binding protein.
Materials and Methods

Materials
Pregnant mare serum gonadotropin (PMSG) was purchased from Calbiochem (EMD Millipore Corp., Billerica, MA (Table 1) . eIF5A hypusination inhibitor, N1-guanyl-1,7-diaminoheptane (GC7) was purchased from LGC Biosearch Technologies (Petaluma, CA). GC7 stock concentration was prepared in 10 mM acetic acid and stored at 220°C for further use. All other chemicals and reagents used were conventional commercial products. 
Animals and treatments
Immature (23-day-old), female Sprague-Dawley rats were purchased from Charles River Laboratories (Wilmington, MA). Animal handling and treatments were conducted in accordance with the accepted standards of humane animal care, as outlined in the Ethical Committee Guidelines of University of Michigan and approved by the institutional animal use and care committee. In some experiments, follicle growth was induced by subcutaneous injection with 50 IU of PMSG; the control animals received saline. To inhibit endogenous eIF5A hypusination, the rats were injected with GC7 (16 mg/kg body weight, intraperitoneally), a specific inhibitor of eIF5A hypusination, or vehicle (1 mM acetic acid) 2 hours before treatment with 50 IU of PMSG. Ovaries were harvested at 14, 28, 42, and 56 hours after PMSG treatment. The ovaries were stored in liquid nitrogen for further use. To isolate rat granulosa cells for the in vitro studies, the 23-day-old immature rats were injected with 17b-estradiol (E2; 1.5 mg/d) for 3 days to stimulate the development of large preantral follicles, and their ovaries were harvested. The rats were euthanized 24 hours after the last estradiol administration by CO 2 asphyxiation. Granulosa cells were isolated and cultured in serum-free Dulbecco's modified Eagle medium (DMEM)-F12 medium.
Rat granulosa cell isolation and culture
Granulosa cells were harvested from immature female rats, as described previously (26) . Briefly, 23-day-old immature female rats were injected subcutaneously with 1.5 mg of E2 for three consecutive days. At 24 hours after the last injection, the animals were euthanized by CO 2 asphyxiation and ovaries were harvested and placed in the medium (phenol red-free DMEM-F12 containing 0.2% bovine serum albumin, 10 mM HEPES, and 6.8 mM EGTA). The ovaries were punctured several times with a 27-gauge needle to release granulosa cells to the medium. Cells were collected and incubated for 15 to 20 minutes at 37°C under an atmosphere of 95% O 2 /5% CO 2 and centrifuged for 5 minutes at 250g. The cell pellets were resuspended in DMEM-F12 containing 0.5 M sucrose, 0.2% bovine serum albumin, and 1.8 mM EGTA, and incubated for 5 minutes at 37°C. After incubation, the cell suspension was diluted with three volumes of serum-free DMEM-F12, centrifuged at 250g, and treated sequentially with trypsin (20 g/mL) for 1 minute, 300 g/mL soybean trypsin inhibitor for 5 minutes, and deoxyribonuclease I (100 g/mL) for 5 minutes at 37°C to remove dead cells. The cells were then rinsed twice with serum-free media and suspended in DMEM-F12 and counted. Cell viability was examined by the trypan blue exclusion method. Cells (1 3 10 6 to 2 3 10 6 cells per 3 mL of medium per 60-mm dish) were seeded and cultured in serum-free DMEM-F12 medium supplemented with 20 mM HEPES (pH 7.4), 4 mM glutamine, 100 IU penicillin/mL, and 100 g/mL streptomycin. Before seeding, the culture dishes were coated with 10% fetal bovine serum for 2 hours at 37°C and washed twice with DMEM-F12 serum-free medium.
Treatment of granulosa cells with FSH, E2, and GC7
After 24 hours of cell culture, the medium was replaced with fresh serum-free medium and the cells were treated with GC7 (1.5 mM) and 1 mM aminoguanidine hydrochloride to prevent destruction by monoamine oxidase, followed 2 hours later by FSH (35 ng/mL) and 17b-estradiol (1 mM) for the indicated times. Inhibition of eIF5A hypusination increases PMSG-induced LHCGR mRNA expression in rat ovaries. We treated 23-day-old rats with eIF5A hypusination inhibitor GC7 for 2 hours, then with 50 IU of PMSG for indicated times. Total RNA was isolated and reverse transcribed; the changes in LHCGR mRNA levels and 18S rRNA were quantified by real-time PCR using specific primers and probes. The results shown are representative of three independent experiments. The graphs represent changes in LHCGR mRNA levels normalized to 18S rRNA and shown as fold change vs control. Error bars represent the mean standard error. *P , 0.05 vs control; #P , 0.05 vs PMSG.
Real-time PCR
Total RNA was extracted from cell pellets or homogenized ovaries by the TRIzol method according to the manufacturer's instructions (Invitrogen). Aliquots of total RNA (1 mg) extracted from different experimental groups were reverse transcribed in a reaction volume of 20 mL using 2.5 M random hexamer, 500 M deoxynucleotide triphosphate, 5.5 mM MgCl 2 , 8 U of ribonuclease inhibitor, and 25 U of multiscribe reverse transcription. The reactions were carried out in a PTC-100 thermal controller (25°C for 10 minutes, 48°C for 30 minutes, and 95°C for 5 minutes; MJ Research, Watertown, MA). The real-time PCR quantification was then performed using 1:5 diluted cDNA in triplicates and predesigned primers and probes for rat LHCGR, LRBP, and 18S (TaqMan Assay on Demand gene expression product; Thermo Fisher Scientific). Reactions were carried out in a final volume of 25 mL using a Thermo Fisher Scientific 7300 real-time PCR system for 40 cycles (95°C for 15 seconds and 60°C for 1 minute) after the initial incubation for 10 minutes at 95°C. The fold change in LHCGR and LRBP gene expression was calculated using the ΔΔCt method (27) , with 18S rRNA as the internal control.
Western blot analysis
Cell and ovarian tissue extracts were prepared using a radioimmunoprecipitation assay (RIPA) buffer containing protease inhibitors. The supernatants were collected after centrifuging the lysates at 10,000 rpm for 15 minutes, and the total protein content was quantitated using bicinchoninic acid assay reagents. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10% and 12%) was used to separate 60 mg of total proteins, which were transferred to nitrocellulose membrane and probed with specific antibodies. Protein loading was normalized by stripping and reprobing the same blots with b-tubulin as indicated in each experiment. Signal detection was performed with the SuperSignal West Femto maximum-sensitivity Western blotting detection kit (Thermo Fisher Scientific).
Statistical analysis
Statistical analysis was carried out using GraphPad Prism software (GraphPad Software, La Jolla, CA). The data were analyzed using one-way analysis of variance followed
Results
Inhibition of endogenous eIF5A hypusination increased FSH-induced LHCGR mRNA expression
Our previous studies have shown that hypusinated eIF5A interacts with LRBP-LHCGR mRNA complex and leads to ligand-induced downregulation of LHCGR mRNA expression, and that inhibition of eIF5A hypusination reverses the downregulation (16). In the current study, using cultured rat granulosa cells, we examined whether eIF5A hypusination plays any role during follicle maturation. The real-time PCR results showed that GC7 treatment produced significant increases in LHCGR mRNA expression at 24 hours and 48 hours when compared with cells treated with FSH and E2 alone (4.32-vs 2.83-fold at 24 hours and 5.93-vs 4.07-fold at 48 hours; Fig. 1 ). These results suggest that endogenous hypusinated eIF5A exerts an inhibitory effect on LHCGR mRNA expression and that the inhibitory effect is eliminated by blocking hypusination.
Hypusination of eIF5A decreased during the FSH-induced LHCGR mRNA expression time frame
We then examined whether conditions that favor increased expression of LHCGR mRNA might suppress eIF5A hypusination. Because FSH treatment has been known to increase LHCGR mRNA expression in growing follicles (4), we examined whether an increase in LHCGR expression is accompanied by a decrease in eIF5A hypusination. The results of the Western blot analyses of the cell lysates from control and FSH-treated samples showed a significant inhibition of hypusinated form of eIF5A at 24 hours and 48 hours of FSH treatment when compared with the control samples (Fig. 2) . GC7 pretreatment further reduced hypusination of eIF5A, as evidenced by a decrease in the 19-kDa band corresponding with the hypusinated form of eIF5A (eIF5A hyp ). Our previous studies (16, 17) have shown that the hypusinated eIF5A appears as a 19-kDa band, whereas the unhypusinated eIF5A migrates faster on the gel and yields a 18-kDa band. These results show that hypusination of eIF5A causes a suppression of LHCGR expression.
Inhibition of eIF5A hypusination increased PMSG-induced LHCGR mRNA expression and decreased eIF5A hypusination in ovaries
After establishing that inhibition of eIF5A hypusination increased the expression of LHCGR mRNA in granulosa cells treated with FSH under in vitro conditions, we examined whether a similar phenomenon could be demonstrated under in vivo conditions. The results of real-time PCR showed that PMSG treatment, as expected, caused a significant upregulation of LHCGR mRNA expression in a time-dependent manner, with a 1.56-fold increase at 14 hours, 2.58-fold at 28 hours, 4.02-fold at 42 hours, and 4.59-fold at 56 hours compared with the control (P , 0.05; Fig. 3) . Interestingly, GC7-pretreated groups showed significant increase in LHCGR mRNA expression at all the time points compared with the group treated with PMSG alone (1.56-vs 3.42-fold at 14 hours; 2.58-vs 4.87-fold at 28 hours; 4.02-vs 5.37-fold at 42 hours; and 4.59-vs 6.15-fold at 56 hours).
The ovaries collected at different time intervals were then examined for eIF5A hypusination. Western blot analyses of the ovarian lysates collected after PMSG treatment showed a significant time-dependent decrease in the expression of endogenous eIF5A
hyp compared with vehicle-treated controls (27% at 28 hours, 69% at 42 hours, and 81% at 56 hours; Fig. 4 , upper panel, lanes 1 through 6). As expected, GC7 pretreatment significantly inhibited endogenous eIF5A hypusination (Fig. 5 , lanes 7 through 10).
Inhibition of eIF5A hypusination by GC7 inhibited LRBP expression
Because hypusination of eIF5A reduces LHCGR mRNA expression, we examined whether inhibition of hypusination during FSH-induced follicular growth bears any relationship with LRBP, which is known to inhibit LHCGR mRNA expression. The results of in vitro real-time PCR experiments showed a significant inhibition of LRBP mRNA at 6, 24, and 48 hours of FSH treatment [0.83-fold vs control at 6 hours, 0.63-fold vs control at 24 hours, and 0.37-fold vs control at 48 hours; Fig. 5(a) ]. GC7 treatment produced further reduction in LRBP mRNA at all time points tested. When LRBP protein expression was examined by Western blot analysis, the results showed a significant inhibition of LRBP protein expression at all the time points of FSH treatment. This LRBP expression was further reduced by GC7 [ Fig. 5(b) ]. Results of the in vivo real-time PCR analyses showed a significant time-dependent Figure 5 . Inhibition of eIF5A hypusination by GC7 inhibits LRBP expression in vitro. Rat granulosa cells were cultured for 24 hours and treated with eIF5A hypusination inhibitor GC7 or vehicle for 2 hours, then with FSH for indicated time points. (a) The total RNA was isolated and the changes in LRBP mRNA expression were quantified by real-time PCR using specific primers and probes. The graphs represent changes in LRBP mRNA levels normalized to 18S rRNA and are shown as fold change vs control. Error bars represent the mean standard error. *P , 0.05 vs control; #P , 0.05 vs FSH and E2. (b) Cells were sonicated using RIPA buffer, and equal amounts of protein from each sample were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The proteins were transferred to nitrocellulose membrane and probed with LRBP antibody. The membranes were stripped and reprobed with b-tubulin antibodies. The blot presented here is the representative of at least three independent experiments. inhibition of LRBP mRNA expression in response to PMSG treatment compared with control. LRBP mRNA expression was inhibited further by pretreatment with GC7 before PMSG treatment [ Fig. 6(a) ]. Western blot analysis of the ovarian RIPA lysates showed a significant inhibition of endogenous LRBP protein expression over the period of PMSG treatment compared with control [17% at 14 hours, 50% at 28 hours, 70% at 42 hours, and 90% at 56 hours; Fig. 6(b),  lanes 1 through 5] . GC7 treatment caused further significant reduction in LRBP expression [ Fig. 6(b), lanes 6 through 9] .
Discussion
Development and growth of follicles from primordial to primary and their subsequent progression through the antral stage to ovulatory follicles is a complex process involving the participation of several negative and positive regulatory factors (28) . This well-orchestrated selection process is necessary for successful ovulation. Follicle growth beyond the late preantral/small antral stage in rodents is critically dependent on FSH (29) . FSH promotes granulosa cell proliferation and growth for follicles to become dominant-a process that is augmented by other autocrine and paracrine factors (29) . FSH then increases the responsiveness of the dominant follicle to LH by increasing the expression of LHCGR (30) . In this study, we demonstrated an additional regulatory mechanism governing the expression of LHCGR mRNA by eIF5A, a ubiquitous protein found in most cells. Initially identified as a translation initiation factor, eIF5A is now known to be involved in many cellular functions, including mRNA shuttling, stress granule formation, proliferation, and apoptosis (19) . eIF5A undergoes hypusination, a unique polyamine-dependent posttranslational modification that is necessary for its functions (31, 32) . Our previous studies have shown that the eIF5A hyp increases the degradation of LHCGR mRNA, a process mediated by the bifunctional protein LRBP. The results of the current study show that a PMSG/FSH-mediated increase in LHCGR mRNA expression during follicle growth caused a further increase in LHCGR mRNA expression when hypusination of eIF5A was inhibited by GC7, a specific inhibitor of the hypusination reaction. Furthermore, inhibition of eIF5A hypusination showed a decrease in the expression of LRBP. We have previously identified LRBP as a negative regulator of LHCGR mRNA expression through its ability to bind LHCGR mRNA and target it for degradation in P bodies (15) . Our present in vivo and in vitro studies show that eIF5A hypusination inhibition resulted in a further enhancement of PMSG/FSH-induced LHCGR mRNA expression, suggesting that eIF5A hypusination plays an inhibitory role in LHCGR expression during FSH-mediated follicular growth. The results show that the expression of eIF5A hypusination decreased significantly in response to FSH treatment. The suppressive effect of eIF5A hypusination on LHCGR mRNA expression is consistent with studies in other systems showing upregulation of mRNAs, including TGF-b (33, 34) , transglutaminase (35) , and p53 (36) , by depleting cellular polyamine, which is the donor of the hypusine group. Although these studies did not examine inhibition of hypusination directly, it has been shown that depletion of polyamines using difluoromethylornithine, an inhibitor of ornithine carboxylase, or inhibition of deoxyhypusine synthase results in the inhibition of eIF5A hypusination (37) . In another study, Mandal et al. (38) showed that adenoviral gene silencing of eIF5A caused several-fold induction of a group of endoplasmic reticulum stress-related proteins (HSPA5/GRP78/ BiP, HSPA1B, HSPD1, CALR, and P4HB). Thus, eIF5A via hypusination exerts suppression of mRNA and protein expression in a variety of systems. Our results are also in agreement with our previous study showing that inhibiting eIF5A hypusination reversed LHCGR mRNA downregulation by increasing functional receptor protein expression during ligand-mediated LHCGR downregulation (16) .
Our previous studies have established that the up-and downregulation of LHCGR mRNA expression during the ovarian cycle occurs by regulating its degradation (39) . LRBP plays a crucial role in the regulated degradation of LHCGR mRNA by targeting the LRBP-bound LHCGR mRNA to the degradation pathway (7). This is supported by the findings of Ikeda et al. (40) , who reported that overexpression of LRBP in granulosa cells resulted in the abolishment of an FSH-induced increase in LHCGR mRNA expression. In the current study, we present evidence showing that time-dependent inhibition of both LRBP mRNA and protein levels occurred during PMSG/FSH treatments. Inhibition of hypusination by GC7 further reduced the LRBP levels over that seen with treatment with PMSG/FSH alone. Thus, it appears that the increased expression of LHCGR mRNA seen during GC7 treatment could be the result of a decrease in LRBP by acting at the transcriptional level. Our findings suggest that the inhibitory effect of eIF5A on FSH-induced LHCGR expression might serve as a regulatory mechanism to prevent overexpression of LHCGR in preparing the dominant follicle for ovulation. It might also serve as a mechanism to protect the ovulatory follicle from ovarian hyperstimulation by limiting the expression of LHCGR. Under basal conditions, endogenous hypusination of eIF5A exerts an inhibitory effect on LHCGR expression. Increased secretion of FSH during follicle growth inhibits eIF5A hypusination, and abrogation of eIF5A hypusination by FSH increases LHCGR expression. Our data clearly show that the effect of eIF5A hypusination on LHCGR expression is mediated by reducing the levels of the LRBP. Because LRBP has been shown to increase LHCGR mRNA degradation (10), the reduction in LRBP levels by inhibiting eIF5A hypusination would suggest that eIF5A, at least in part, regulates LHCGR mRNA expression by controlling its degradation.
